See more : Mission Produce, Inc. (AVO) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Shyndec Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- NZME Limited (NZM.AX) Income Statement Analysis – Financial Results
- Harper Hygienics S.A. (HRP.WA) Income Statement Analysis – Financial Results
- Torex Gold Resources Inc. (0VL5.L) Income Statement Analysis – Financial Results
- ATON Inc. (158430.KQ) Income Statement Analysis – Financial Results
- SalMar ASA (SALRF) Income Statement Analysis – Financial Results
Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.shyndec.com
About Shanghai Shyndec Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd. manufactures drug preparation products in China and internationally. It focuses on anti-infection, cardiovascular and cerebrovascular, anti-tumor, metabolism, and endocrine areas. The company was founded in 1996 and is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.93B | 12.96B | 13.94B | 12.56B | 12.20B | 11.32B | 8.52B | 9.13B | 2.68B | 2.75B | 2.35B | 2.01B | 1.70B | 1.42B | 1.16B | 687.23M | 624.32M | 545.87M | 502.75M | 358.53M | 382.91M | 227.58M | 149.10M |
| Cost of Revenue | 7.54B | 8.02B | 7.85B | 6.65B | 6.14B | 5.80B | 4.83B | 5.83B | 1.36B | 1.47B | 1.37B | 1.33B | 1.17B | 987.46M | 817.92M | 436.53M | 397.72M | 354.92M | 316.30M | 216.26M | 262.18M | 137.93M | 68.56M |
| Gross Profit | 4.39B | 4.93B | 6.10B | 5.91B | 6.06B | 5.52B | 3.69B | 3.30B | 1.32B | 1.28B | 980.95M | 676.81M | 529.09M | 435.50M | 346.31M | 250.71M | 226.61M | 190.95M | 186.45M | 142.28M | 120.74M | 89.65M | 80.54M |
| Gross Profit Ratio | 36.83% | 38.08% | 43.72% | 47.08% | 49.68% | 48.78% | 43.33% | 36.15% | 49.36% | 46.38% | 41.75% | 33.72% | 31.07% | 30.61% | 29.75% | 36.48% | 36.30% | 34.98% | 37.09% | 39.68% | 31.53% | 39.39% | 54.02% |
| Research & Development | 569.43M | 520.92M | 589.18M | 498.93M | 417.17M | 373.64M | 319.17M | 340.33M | 81.43M | 93.87M | 85.79M | 50.41M | 36.69M | 41.04M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.93M | 125.71M | 146.14M | 111.61M | 110.96M | 119.22M | 117.58M | 134.85M | 34.16M | 42.20M | 24.58M | 17.50M | 13.28M | 13.70M | 97.91M | 84.44M | 43.82M | 59.27M | 53.88M | 43.59M | 39.01M | 28.08M | 34.22M |
| Selling & Marketing | 1.85B | 2.75B | 3.48B | 3.40B | 3.61B | 3.24B | 1.49B | 1.01B | 584.94M | 645.91M | 518.54M | 338.78M | 235.88M | 163.69M | 124.49M | 83.11M | 55.96M | 57.11M | 55.43M | 40.76M | 41.76M | 30.76M | 26.55M |
| SG&A | 2.78B | 2.87B | 3.63B | 3.51B | 3.72B | 3.36B | 1.61B | 1.14B | 619.10M | 688.11M | 543.12M | 356.28M | 249.16M | 177.39M | 222.40M | 167.54M | 99.78M | 116.38M | 109.31M | 84.34M | 80.76M | 58.84M | 60.77M |
| Other Expenses | -22.99M | 593.90M | 654.63M | 619.99M | 672.16M | 34.11M | 7.41M | 138.27M | 17.09M | 48.89M | 36.46M | 15.96M | 16.15M | 14.54M | 14.49M | 6.34M | 2.64M | 2.62M | 3.78M | 1.81M | 1.11M | 3.80M | 3.03M |
| Operating Expenses | 3.54B | 3.99B | 4.87B | 4.63B | 4.81B | 4.44B | 2.52B | 2.08B | 882.31M | 953.29M | 765.28M | 490.60M | 358.44M | 288.09M | 225.92M | 169.84M | 102.19M | 117.84M | 110.52M | 85.22M | 81.53M | 59.56M | 61.35M |
| Cost & Expenses | 10.99B | 12.01B | 12.72B | 11.27B | 10.95B | 10.24B | 7.35B | 7.91B | 2.24B | 2.43B | 2.13B | 1.82B | 1.53B | 1.28B | 1.04B | 606.36M | 499.91M | 472.77M | 426.82M | 301.47M | 343.71M | 197.49M | 129.91M |
| Interest Income | 109.02M | 59.35M | 48.84M | 36.78M | 51.65M | 34.31M | 20.91M | 17.23M | 5.29M | 10.76M | 6.35M | 5.36M | 2.70M | 1.59M | -0.43 | 3.55M | 2.75M | 3.74M | 2.58M | 1.03M | 241.02K | 371.58K | 388.13K |
| Interest Expense | 57.88M | 107.31M | 110.47M | 123.51M | 189.44M | 215.66M | 253.69M | 291.45M | 91.94M | 57.32M | 26.24M | 20.36M | 8.67M | 2.55M | 1.98M | 1.40M | 824.15K | 475.00K | 256.87K | 2.20M | 1.94M | 1.03M | 523.94K |
| Depreciation & Amortization | 825.25M | 848.54M | 824.19M | 736.69M | 730.86M | 738.35M | 784.32M | 726.55M | 160.44M | 104.64M | 74.38M | 56.60M | 40.26M | 31.25M | 25.93M | 22.75M | 22.34M | 18.96M | 16.99M | 11.02M | 3.00M | 4.36M | 3.30M |
| EBITDA | 1.98B | 1.94B | 1.85B | 1.89B | 1.98B | 2.23B | 2.00B | 2.05B | 633.17M | 460.02M | 316.99M | 262.24M | 218.52M | 187.86M | 153.81M | 107.59M | 154.39M | 97.06M | 98.44M | 70.39M | 39.99M | 34.40M | 21.40M |
| EBITDA Ratio | 16.58% | 15.15% | 14.83% | 15.73% | 16.90% | 20.66% | 23.43% | 23.29% | 23.61% | 17.67% | 14.34% | 13.06% | 13.29% | 13.31% | 12.71% | 15.66% | 25.08% | 17.78% | 19.57% | 19.63% | 10.44% | 15.12% | 14.36% |
| Operating Income | 1.08B | 966.14M | 1.25B | 1.02B | 1.03B | 1.26B | 946.38M | 907.82M | 337.69M | 252.97M | 180.17M | 169.99M | 153.74M | 139.52M | 111.41M | 77.21M | 128.51M | 75.12M | 79.25M | 55.58M | 36.99M | 30.04M | 18.10M |
| Operating Income Ratio | 9.07% | 7.46% | 8.94% | 8.16% | 8.45% | 11.13% | 11.11% | 9.95% | 12.59% | 9.20% | 7.67% | 8.47% | 9.03% | 9.80% | 9.57% | 11.24% | 20.58% | 13.76% | 15.76% | 15.50% | 9.66% | 13.20% | 12.14% |
| Total Other Income/Expenses | 14.93M | 17.98M | -318.31M | 16.93M | 41.77M | 12.00M | -9.36M | 138.13M | 68.09M | 44.17M | 36.20M | 14.18M | 15.85M | 14.54M | 14.49M | 481.85K | 2.64M | 2.51M | 1.92M | 1.59M | 1.06M | 3.33M | 2.78M |
| Income Before Tax | 1.10B | 984.12M | 918.21M | 1.04B | 1.07B | 1.29B | 953.78M | 1.04B | 352.63M | 297.14M | 216.37M | 185.19M | 169.59M | 154.06M | 125.90M | 83.55M | 131.16M | 77.63M | 81.17M | 57.17M | 38.06M | 33.37M | 20.88M |
| Income Before Tax Ratio | 9.19% | 7.59% | 6.58% | 8.29% | 8.79% | 11.43% | 11.20% | 11.36% | 13.15% | 10.81% | 9.21% | 9.23% | 9.96% | 10.83% | 10.81% | 12.16% | 21.01% | 14.22% | 16.14% | 15.95% | 9.94% | 14.66% | 14.00% |
| Income Tax Expense | 131.95M | 116.63M | 97.06M | 141.08M | 144.39M | 223.96M | 135.21M | 182.48M | 61.07M | 49.60M | 28.86M | 33.52M | 22.67M | 20.94M | 17.20M | 10.97M | 18.05M | 11.34M | 10.64M | 8.52M | 4.82M | 6.95M | 3.59M |
| Net Income | 691.88M | 867.48M | 821.15M | 900.05M | 928.47M | 705.52M | 515.80M | 476.93M | 221.05M | 189.99M | 132.79M | 115.94M | 120.03M | 108.11M | 89.05M | 53.91M | 94.03M | 50.50M | 58.69M | 36.83M | 23.43M | 21.90M | 14.58M |
| Net Income Ratio | 5.80% | 6.69% | 5.89% | 7.17% | 7.61% | 6.23% | 6.06% | 5.23% | 8.24% | 6.91% | 5.65% | 5.78% | 7.05% | 7.60% | 7.65% | 7.85% | 15.06% | 9.25% | 11.67% | 10.27% | 6.12% | 9.62% | 9.78% |
| EPS | 0.54 | 0.84 | 0.80 | 0.88 | 0.90 | 0.65 | 0.46 | 0.43 | 0.56 | 0.33 | 0.23 | 0.22 | 0.21 | 0.19 | 0.15 | 0.10 | 0.16 | 0.09 | 0.10 | 0.06 | 0.07 | 0.04 | 0.03 |
| EPS Diluted | 0.54 | 0.75 | 0.70 | 0.76 | 0.81 | 0.65 | 0.46 | 0.43 | 0.56 | 0.33 | 0.23 | 0.22 | 0.21 | 0.19 | 0.15 | 0.10 | 0.16 | 0.09 | 0.10 | 0.06 | 0.07 | 0.04 | 0.03 |
| Weighted Avg Shares Out | 1.27B | 1.03B | 1.03B | 1.03B | 1.03B | 1.09B | 1.11B | 1.11B | 946.08M | 575.38M | 575.34M | 575.45M | 575.42M | 575.52M | 575.46M | 575.49M | 575.46M | 575.61M | 575.58M | 575.58M | 575.58M | 575.58M | 575.58M |
| Weighted Avg Shares Out (Dil) | 1.27B | 1.16B | 1.18B | 1.18B | 1.15B | 1.09B | 1.11B | 1.11B | 946.16M | 575.47M | 575.46M | 575.45M | 575.42M | 575.52M | 575.46M | 575.49M | 575.46M | 575.61M | 575.58M | 575.58M | 575.58M | 575.58M | 575.58M |
No news found for: 600420.SS
Source: https://incomestatements.info
Category: Stock Reports